# Baxter Healthcare Corporation – FDA Inspection, Sep 29, 2025

Source: https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/bca90a34-d045-41e0-8c4a-1c7913aa79df
Source feed: FDA_Inspections

> FDA inspection 1284446 of Baxter Healthcare Corporation, September 29, 2025. Classification: Official Action Indicated (OAI). 5 citations under 21 CFR part 211. Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1284446
- Company Name: Baxter Healthcare Corporation
- Inspection Date: 2025-09-29
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Orleans District Office
- Citation Count: 5

## Related Documents

- FDA Inspection 1210861 - 2023-07-14
- [FDA Inspection 1072203 - 2018-11-20](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/c9feb4e5-d47a-4f96-b8b4-93ff0d859b9d)
- FDA Inspection 1010362 - 2017-03-29
- FDA Inspection 983354 - 2016-04-27
- FDA Inspection 920235 - 2015-03-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/baxter-healthcare-corporation/738590ab-c241-4de1-aaec-722e154bfc45

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea